Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 10689 - 10696 of 12007 results

The Regional Greenhouse Gas Initiative: Will It Survive Federal Regulation of Greenhouse Gases?

January 16, 2014| Article| Viewpoint

BREAKING NEWS: FTC Announces Major Settlement with Apple

January 15, 2014| Blog| Viewpoint

Winter Weather Woes: What are My Obligations to Pay Employees During Inclement Weather?

January 15, 2014| Blog| Viewpoint

Is New Jersey’s “Need Not Apply” Law Prohibiting Employers from Publishing Ads Discouraging Unemployed Job Seekers from Applying Constitutional? Yes, Says Court

January 15, 2014| Blog| Viewpoint

ML Strategies Weekly Energy and Environment Update – Week of January 13, 2014

January 14, 2014| Blog| Viewpoint

Three Hot Topics Addressed by Recent FAQs: ACA Cost Sharing, Wellness Programs and the MHPAEA

January 14, 2014| Blog| Viewpoint

Privacy Monday - January 13, 2014

January 13, 2014| Blog| Viewpoint

Health Care Enforcement in 2013: A Year in Review

January 13, 2014| Advisory| Viewpoint

News & Press Releases

Mintz Advises ArriVent BioPharma on $75 Million Underwritten Public Offering

July 08, 2025

Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“

Mintz Advises S2G Investments on $40M Series B Financing of Sojo Industries

July 07, 2025

Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

View all News and Press Releases